May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Evaluation of Acute Effects of Intraocular Delivery of Beta–radiation
Author Affiliations & Notes
  • G.Y. Fujii
    Ophthalmology, Doheny Eye Institute, Los Angeles, CA
  • J.V. Rossi
    Ophthalmology, Doheny Eye Institute, Los Angeles, CA
  • D.R. Hinton
    Ophthalmology, Doheny Eye Institute, Los Angeles, CA
  • M.S. Humayun
    Ophthalmology, Doheny Eye Institute, Los Angeles, CA
  • S. Sadda
    Ophthalmology, Doheny Eye Institute, Los Angeles, CA
  • A. Barnes
    Ophthalmology, Doheny Eye Institute, Los Angeles, CA
  • M. McCormick
    Ophthalmology, Doheny Eye Institute, Los Angeles, CA
  • R. Trip
    Innovation Factory, Atlanta, GA
  • L. Faupel
    Innovation Factory, Atlanta, GA
  • E. deJuan Jr
    Ophthalmology, Doheny Eye Institute, Los Angeles, CA
  • Footnotes
    Commercial Relationships  G.Y. Fujii, None; J.V. Rossi, None; D.R. Hinton, None; M.S. Humayun, None; S. Sadda, None; A. Barnes, None; M. McCormick, None; R. Trip, None; L. Faupel, None; E. deJuan Jr, None.
  • Footnotes
    Support  none
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 5138. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      G.Y. Fujii, J.V. Rossi, D.R. Hinton, M.S. Humayun, S. Sadda, A. Barnes, M. McCormick, R. Trip, L. Faupel, E. deJuan Jr; Evaluation of Acute Effects of Intraocular Delivery of Beta–radiation . Invest. Ophthalmol. Vis. Sci. 2004;45(13):5138.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To evaluate and quantify the acute effects of focal intraocular delivery of beta radiation on retinal and subretinal tissue over a prescribed dose range. Methods: Eighty rabbits underwent pars plana vitrectomy and received controlled intraocular strontium90 beta–radiation using a novel radiation probe. Eight study groups of 10 rabbits each, received 2 dosages in different retinal locations. The following dosages were evaluated: 0, 13, 19, 26, 32, 38, 41, 51, 62, 77, 82, 103, 123, 164, and 246 Gy. Rabbits were followed for 1 (N=40) or 2 months (N=40). Main outcome measures included changes in the fundus appearance, fluorescein angiography (FA), electroretinography (ERG) and histology. Primary tissues of interest are the neural retina, retinal pigment epithelium (RPE), Bruch’s membrane/choriocapillaris complex, and choroid. Results: Controlled intraocular delivery of beta–radiation was achieved in all eyes. No intra–operative or peri–operative complications were observed. No detectable change was observed on electroretinography in any of the rabbits at 4 and 8 weeks. No abnormalities in fundus appearance, FA, or light microscopy were observed in any animals receiving 103 Gy or less. However, in subgroups receiving 123 Gy or more, changes were observed including retinal vascular attenuation, myelin atrophy, retinal vessel obliteration, RPE atrophy, and RPE proliferation on biomicroscopy (and in color photographs). In addition, FA in these animals revealed retinal vascular non–perfusion, abnormal hyperfluorescence, and delayed choroidal filling. Light microscopy disclosed changes in the outer nuclear layer and subretinal space, including retinal gliosis, RPE proliferation, decreased pigmentation or hyperpigmentation of RPE, RPE loss, RPE atrophy and RPE hypertrophy. No progression of these acute toxic effects was observed between 4 and 8 weeks after radiation exposure. Conclusions: Short–term toxicity data demonstrates that the minimum threshold for acute damage with this approach is above 103 Gy. Further studies to evaluate the role of local delivery of strontium90 beta–radiation in the treatment of AMD are warranted.

Keywords: radiation therapy • pathology: experimental • retina 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×